ReviewLife (Basel, Switzerland)2026
Amplatzer-Based Transcatheter Paravalvular Leak Closure: A Narrative Review of Device Design, Procedural Strategy, Safety, and Outcomes.
Review in Life (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Paravalvular leak (PVL) is a clinically important complication of surgical prosthetic valve replacement that may lead to heart failure, hemolytic anemia, and repeat intervention. Transcatheter closure has become an accepted alternative to redo surgery in selected high-risk patients, with Amplatzer devices serving as a widely used platform because of their versatility across irregular and crescentic defects. This narrative review summarizes contemporary evidence on the role of Amplatzer-based devices in PVL closure, with an emphasis on device design, imaging-guided procedural strategies, clinical outcomes, safety, comparison with alternative occlusion systems, and future directions. Available data from registries, cohort studies, and comparative observational series indicate high technical success, meaningful improvement in symptoms and hemolysis-related burden, and acceptable medium-term durability in appropriately selected patients. Outcomes, however, remain strongly influenced by leak morphology, prosthetic valve characteristics, access route, imaging quality, and operator experience. Important limitations of the current evidence include the absence of randomized trials, nonuniform endpoint definitions, heterogeneous imaging protocols, and limited long-term comparative durability data. In contemporary structural heart practice, Amplatzer devices remain a widely used and practical platform for transcatheter PVL repair, particularly in experienced centers managing anatomically complex leaks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.